Jefferies cuts Neuren Pharmaceuticals price target 1.7% to A$28.90
Jefferies lowered its price target on Neuren Pharmaceuticals by 1.7% to A$28.90 per share.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.